After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.
Pheonix-Based Cardiology Group Continues to Expand Access to Care Across ValleyPHOENIX, Dec. 26, 2025 /PRNewswire/ -- ...
I felt fine, but my Whoop data told a different story. Paying attention led to early detection and a successful treatment.
Background The growing population of patients with adult congenital heart disease (ACHD) present complex lifelong care needs ...
Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.
Jordan News Agency (Petra) on MSN
Local hospital performs first cardiac ablation procedures for arrhythmia
The King Abdullah University Hospital (KAUH) has performed its first catheter-based cardiac ablation procedures for the treatment of cardiac arrhythmias, using advanced electrophysiology and cardiac ...
Abbott will soon enter the competitive U.S. pulsed field ablation (PFA) market, having just received FDA approval for its ...
The FDA approved Abbott's Volt PFA System for atrial fibrillation, supported by VOLT-AF trial data showing strong safety and ...
TipRanks on MSN
Boston Scientific’s global pulsed field ablation trial targets persistent atrial fibrillation growth
Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewThis global Boston Scientific trial, officially titled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback